🔎 Trials Near Me

መነሻ › የሳንባ ካንሰር › Tennessee › Nashville

በNashville፣ TN ለየሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሳንባ ካንሰር የሚደረጉ 40 ጥናቶች በNashville እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 12 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04585750

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06172478

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06625775

Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ሴፕቴ 2026 · NCT06765109

A Study of PHN-012 in Patients With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • PHN-012-001 Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT07127874

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners - Tennessee, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ሴፕቴ 2026 · NCT06881784

Phase 1 Study of PF-08046033 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute- Pharmacy, Nashville
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07519655

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Sarah Cannon Research Institute, Nashville
  • United States Oncology Regulatory Affairs Corporate Office, Nashville
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT05920356

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • SCRI Oncology Partners, Nashville
  • Tennessee Oncology, PLLC-Elliston Place Plaza Medical Oncology &Hematology, Nashville
  • Tennessee Oncology, PLLC - Saint Thomas West, Nashville
  • እና 3 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07154290

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Research Site, Nashville
  • Research Site, Nashville
እድሜ ከ18 እስከ 95 · ሁሉም ጾታዎች · የተሻሻለው በ23 ሴፕቴ 2026 · NCT05061550

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06712316

Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT07100080

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institue, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ሴፕቴ 2026 · NCT06128551

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Tennessee Oncology, PLLC, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT07629960

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Canon Research Institute (SCRI) Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT05786924

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ሴፕቴ 2026 · NCT06293898

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
  • SCRI Oncology Partners, Nashville
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06561685

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Tennessee Oncology, Nashville
  • USO - US Oncology Research Network, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06119581

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06343402

Collecting and Analyzing Tissue Samples From Patients Undergoing Surgery for Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ ከ18 እስከ 120 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT00897117

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute Oncology Partners (SCRI-Nashville), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT05592626

Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Xencor Investigative Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ኦገስ 2026 · NCT05433142

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ30 ጁን 2026 · NCT06162221

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon, SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT04678648

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጁን 2026 · NCT06051695

A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Research Site, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06835569

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT06040541

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Sarah Cannon Research Institute, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሜይ 2026 · NCT05379985

Molecular Predictors of Cancer in Patients at High Risk of Lung Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Vanderbilt-Ingram Cancer Center, Nashville
  • Veterans Affairs Medical Center - Nashville, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ27 ኤፕሪ 2026 · NCT00898313

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ22 ኤፕሪ 2026 · NCT07020221

A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • SCRI Oncology Partners, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ማርች 2026 · NCT05948865

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI) Oncology Partners, Nashville
  • Vanderbilt University Medical Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ፌብሩ 2026 · NCT06778863

EBUS-TBNA vs Transbronchial Mediastinal Cryobiopsy for Adequacy of Next Generation Sequencing

ተሳታዮችን በመፈለግ ላይደረጃ 4
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ፌብሩ 2026 · NCT06105801

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • Vanderbilt-Ingram Cancer Center, Nashville
እድሜ 40 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጃንዩ 2026 · NCT05366881

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of TJ101 in Patients With Advanced/Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • Sarah Cannon Research Institute (SCRI), Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ12 ጃንዩ 2026 · NCT07181473

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Massive Bio SYNERGY-AI site, Nashville
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኦክቶ 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Tennessee Oncology, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2025 · NCT05941507

Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦክቶ 2024 · NCT05501665

Phase I/II Trial in ES-SCLC to Enhance Response to Atezolizumab Plus Chemotherapy With Total Body Irradiation

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Vanderbilt University/Ingram Cancer Center, Nashville
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁን 2024 · NCT06110572

በሌሎች ከተሞች ለየሳንባ ካንሰር የሚደረጉ ጥናቶች

በNashville ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ6 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።